A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse

Clinical trial NCT00546780 · COMPLETED

Trial details

NCT number: NCT00546780
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-02-01
Primary completion: 2010-03-01
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.